創薬情報システムの世界市場

◆英語タイトル:Drug Discovery Informatics - Global Market Outlook (2015-2022)
◆商品コード:SMRC65073
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:129
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:IT
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥460,650見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥582,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、創薬情報システムの世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・創薬情報システムの世界市場:モード別分析/市場規模
・創薬情報システムの世界市場:サービス別分析/市場規模
・創薬情報システムの世界市場:地域別分析/市場規模
・創薬情報システムのアメリカ市場規模予測
・創薬情報システムのヨーロッパ市場規模予測
・創薬情報システムのアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Drug Discovery Informatics Market is accounted for $1.91 billion in 2015 and is expected to reach $6.94 billion by 2022 growing at a CAGR of 17.5% from 2015 to 2022. The rising demand for computational technology is the primary factor favouring the market growth. Furthermore, Drug discovery industry and rising number of technologically advanced products are the key drivers for the Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases the use of in-silico models for early ADME/Toxicity screening.
Sequence analysis platforms services accounted the largest revenue share and are expected to continue and dominate the market over the forecast period. North America commanded the largest share driven by the increasing demand for computational technology. However, Asia Pacific is projected to register the fastest growth over the forecast period owing to technological developments in the software and drug nano technology fields carried out in the developing economies.

Some of the key players in the market include ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., BoehringerIngelheim GmBh,, DiscoverX, Charles River Laboratories, Covance, Collaborative Drug Discovery Inc., Novo Informatics, UCB and Evotec.

Modes Covered:
• In-house Informatics
• Outsourced Informatics

Services Covered:
• Molecular Modelling
• Sequence Analysis Platforms
• Docking
• Clinical Trial Data Management
• Other Services

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Drug Discovery Informatics Market, By Mode
5.1 Introduction
5.2 Outsourced Informatics
5.3 In-house Informatics

6 Global Drug Discovery Informatics Market, By Services
6.1 Introduction
6.2 Sequence Analysis Platforms
6.3 Docking
6.4 Clinical Trial Data Management
6.5 Molecular Modeling
6.6 Other Services

7 Global Drug Discovery Informatics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 ChemAxon
9.2 GVK Biosciences
9.3 Jubilant Biosys
9.4 Selvita
9.5 Certara
9.6 Infosys
9.7 Albany Molecular Research Inc.
9.8 BoehringerIngelheimGmBh
9.9 DiscoverX
9.10 Charles River Laboratories
9.11 Covance
9.12 Collaborative Drug Discovery Inc.
9.13 Novo Informatics.
9.14 UCB
9.15 Evotec

List of Tables
Table 1 Global Drug Discovery Informatics Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Drug Discovery Informatics Market Outlook, By Mode (2015-2022) ($MN)
Table 3 Global Drug Discovery Informatics Market Outlook, By In-house Informatics (2015-2022) ($MN)
Table 4 Global Drug Discovery Informatics Market Outlook, By Outsourced Informatics (2015-2022) ($MN)
Table 5 Global Drug Discovery Informatics Market Outlook, By Services (2015-2022) ($MN)
Table 6 Global Drug Discovery Informatics Market Outlook, By Molecular Modeling (2015-2022) ($MN)
Table 7 Global Drug Discovery Informatics Market Outlook, By Sequence Analysis Platforms (2015-2022) ($MN)
Table 8 Global Drug Discovery Informatics Market Outlook, By Docking (2015-2022) ($MN)
Table 9 Global Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (CNS) (2015-2022) ($MN)
Table 10 Global Drug Discovery Informatics Market Outlook, By Other Services (2015-2022) ($MN)
Table 18 North America Drug Discovery Informatics Market Outlook, By Mode (2015-2022) ($MN)
Table 19 North America Drug Discovery Informatics Market Outlook, By In-house Informatics (2015-2022) ($MN)
Table 20 North America Drug Discovery Informatics Market Outlook, By Outsourced Informatics (2015-2022) ($MN)
Table 21 North America Drug Discovery Informatics Market Outlook, By Services (2015-2022) ($MN)
Table 22 North America Drug Discovery Informatics Market Outlook, By Molecular Modeling (2015-2022) ($MN)
Table 23 North America Drug Discovery Informatics Market Outlook, By Sequence Analysis Platforms (2015-2022) ($MN)
Table 24 North America Drug Discovery Informatics Market Outlook, By Docking (2015-2022) ($MN)
Table 25 North America Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (CNS) (2015-2022) ($MN)
Table 26 North America Drug Discovery Informatics Market Outlook, By Other Services (2015-2022) ($MN)
Table 27 Europe Drug Discovery Informatics Market Outlook, By Mode (2015-2022) ($MN)
Table 28 Europe Drug Discovery Informatics Market Outlook, By In-house Informatics (2015-2022) ($MN)
Table 29 Europe Drug Discovery Informatics Market Outlook, By Outsourced Informatics (2015-2022) ($MN)
Table 30 Europe Drug Discovery Informatics Market Outlook, By Services (2015-2022) ($MN)
Table 31 Europe Drug Discovery Informatics Market Outlook, By Molecular Modeling (2015-2022) ($MN)
Table 32 Europe Drug Discovery Informatics Market Outlook, By Sequence Analysis Platforms (2015-2022) ($MN)
Table 34 Europe Drug Discovery Informatics Market Outlook, By Docking (2015-2022) ($MN)
Table 35 Europe Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (CNS) (2015-2022) ($MN)
Table 36 Europe Drug Discovery Informatics Market Outlook, By Other Services (2015-2022) ($MN)
Table 37 Asia Pacific Drug Discovery Informatics Market Outlook, By Mode (2015-2022) ($MN)
Table 38 Asia Pacific Drug Discovery Informatics Market Outlook, By In-house Informatics (2015-2022) ($MN)
Table 39 Asia Pacific Drug Discovery Informatics Market Outlook, By Outsourced Informatics (2015-2022) ($MN)
Table 40 Asia Pacific Drug Discovery Informatics Market Outlook, By Services (2015-2022) ($MN)
Table 41 Asia Pacific Drug Discovery Informatics Market Outlook, By Molecular Modeling (2015-2022) ($MN)
Table 42 Asia Pacific Drug Discovery Informatics Market Outlook, By Sequence Analysis Platforms (2015-2022) ($MN)
Table 43 Asia Pacific Drug Discovery Informatics Market Outlook, By Docking (2015-2022) ($MN)
Table 44 Asia Pacific Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (CNS) (2015-2022) ($MN)
Table 45 Asia Pacific Drug Discovery Informatics Market Outlook, By Other Services (2015-2022) ($MN)
Table 46 Rest of the World Drug Discovery Informatics Market Outlook, By Mode (2015-2022) ($MN)
Table 47 Rest of the World Drug Discovery Informatics Market Outlook, By In-house Informatics (2015-2022) ($MN)
Table 48 Rest of the World Drug Discovery Informatics Market Outlook, By Outsourced Informatics (2015-2022) ($MN)
Table 50 Rest of the World Drug Discovery Informatics Market Outlook, By Services (2015-2022) ($MN)
Table 51 Rest of the World Drug Discovery Informatics Market Outlook, By Molecular Modeling (2015-2022) ($MN)
Table 52 Rest of the World Drug Discovery Informatics Market Outlook, By Sequence Analysis Platforms (2015-2022) ($MN)
Table 53 Rest of the World Drug Discovery Informatics Market Outlook, By Docking (2015-2022) ($MN)
Table 54 Rest of the World Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (CNS) (2015-2022) ($MN)
Table 55 Rest of the World Drug Discovery Informatics Market Outlook, By Other Services (2015-2022) ($MN)



【レポートのキーワード】

創薬情報システム、新薬開発、シーケンス解析、治験データ管理、分子モデリング

★調査レポート[創薬情報システムの世界市場]販売に関する免責事項
★調査レポート[創薬情報システムの世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆